Relmada Therapeutics, Inc. RLMD Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s net change in cash?
- Relmada Therapeutics, Inc. (RLMD) reported net change in cash of $6.28M in Q1 2026.
- How has Relmada Therapeutics, Inc.'s net change in cash changed year-over-year?
- Relmada Therapeutics, Inc.'s net change in cash increased by 332.0% year-over-year, from -$2.71M to $6.28M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.